# Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion

Study · id `cardio:ct-nct05827042` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05827042](<https://clinicaltrials.gov/study/NCT05827042>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05827042

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 338 participants.

## Technical summary

Registry record NCT05827042. Randomized; single masking; primary purpose treatment. Start 2023-05-09 (actual); primary completion 2026-04-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 338 participants (enrolled count; ClinicalTrials.gov record NCT05827042, source copy `cardio:ctgov-nct05827042-2026-08-12`, retrieved 2026-10-26)
- Started: 2023-05-09 (actual) (ClinicalTrials.gov record NCT05827042, source copy `cardio:ctgov-nct05827042-2026-08-12`, retrieved 2026-10-26)
- Primary completion: 2026-04-07 (actual) (ClinicalTrials.gov record NCT05827042, source copy `cardio:ctgov-nct05827042-2026-08-12`, retrieved 2026-10-26)
- Completion: 2026-04-07 (actual) (ClinicalTrials.gov record NCT05827042, source copy `cardio:ctgov-nct05827042-2026-08-12`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05827042, source copy `cardio:ctgov-nct05827042-2026-08-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05827042-2026-08-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion
- Condition: Basilar Artery Occlusion
- Condition: Acute Cerebrovascular Accident
- Condition: Stroke Due to Basilar Artery Occlusion
- Intervention (Drug): Intravenous thrombolysis
- Intervention (Procedure): Endovascular thrombectomy
- Lead sponsor: The First Affiliated Hospital of University of Science and Technology of China
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: The First Affiliated Hospital of University of Science and Technology of China (`cardio:org-the-first-affiliated-hospital-of-university-of-science-and-03d159`)

## Provenance

Content hash: 49db9a87990e6ae30fa18f67da6926d47d03168794f753b463fc7df808848847
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
